Build Your Comparison

Side-by-side financial analysis
FORA logo
FORA
MMSI logo
MMSI
KO logo
KO
PEP logo
PEP
ITGR logo
ITGR
JPM logo
JPM
Try popular comparisons:

Stock Comparison

FORA vs MMSI vs KO vs PEP vs ITGR vs JPM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FORA
Forian Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$68M
5Y Perf.-78.5%
MMSI
Merit Medical Systems, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$4.01B
5Y Perf.+13.9%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$341.71B
5Y Perf.+49.4%
PEP
PepsiCo, Inc.

Beverages - Non-Alcoholic

Consumer DefensiveNASDAQ • US
Market Cap$194.09B
5Y Perf.+12.0%
ITGR
Integer Holdings Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$3.13B
5Y Perf.-3.9%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$908.57B
5Y Perf.+105.8%

FORA vs MMSI vs KO vs PEP vs ITGR vs JPM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FORA logoFORA
MMSI logoMMSI
KO logoKO
PEP logoPEP
ITGR logoITGR
JPM logoJPM
IndustryMedical - Healthcare Information ServicesMedical - Instruments & SuppliesBeverages - Non-AlcoholicBeverages - Non-AlcoholicMedical - DevicesBanks - Diversified
Market Cap$68M$4.01B$341.71B$194.09B$3.13B$908.57B
Revenue (TTM)$30M$1.54B$49.28B$93.92B$1.85B$280.33B
Net Income (TTM)$-5M$139M$13.70B$8.24B$142M$57.05B
Gross Margin46.8%48.7%61.7%54.1%23.3%60.0%
Operating Margin-13.4%12.2%29.3%12.2%10.4%25.9%
Forward P/E16.5x24.3x16.4x15.0x14.6x
Total Debt$12K$898M$45.49B$49.90B$1.40B$942.38B
Cash & Equiv.$13M$449M$10.27B$9.16B$17M$343.34B

FORA vs MMSI vs KO vs PEP vs ITGR vs JPMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FORA
MMSI
KO
PEP
ITGR
JPM
StockMar 21May 26Return
Forian Inc. (FORA)10021.5-78.5%
Merit Medical Syste… (MMSI)100113.9+13.9%
The Coca-Cola Compa… (KO)100149.4+49.4%
PepsiCo, Inc. (PEP)100112.0+12.0%
Integer Holdings Co… (ITGR)10096.1-3.9%
JPMorgan Chase & Co. (JPM)100205.8+105.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: FORA vs MMSI vs KO vs PEP vs ITGR vs JPM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: FORA and KO are tied at the top with 2 categories each (6-stock set) — the right choice depends on your priorities. The Coca-Cola Company is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. JPM and PEP also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
FORA
Forian Inc.
The Growth Play

FORA has the current edge in this matchup, primarily because of its strength in growth exposure and sleep-well-at-night.

  • Rev growth 50.1%, EPS growth 23.0%, 3Y rev CAGR 22.6%
  • Lower volatility, beta 0.21, Low D/E 0.0%, current ratio 2.97x
  • 50.1% revenue growth vs KO's 1.9%
  • Beta 0.21 vs JPM's 0.87, lower leverage
Best for: growth exposure and sleep-well-at-night
MMSI
Merit Medical Systems, Inc.
The Defensive Pick

MMSI is the clearest fit if your priority is defensive.

  • Beta 0.58, current ratio 4.34x
Best for: defensive
KO
The Coca-Cola Company
The Quality Compounder

KO is the #2 pick in this set and the best alternative if quality and efficiency is your priority.

  • 27.8% margin vs FORA's -17.0%
  • 13.1% ROA vs FORA's -11.8%, ROIC 15.8% vs -7.5%
Best for: quality and efficiency
PEP
PepsiCo, Inc.
The Income Pick

PEP is the clearest fit if your priority is income & stability.

  • Dividend streak 54 yrs, beta -0.09, yield 3.9%
  • 3.9% yield, 54-year raise streak, vs KO's 2.6%, (3 stocks pay no dividend)
Best for: income & stability
ITGR
Integer Holdings Corporation
The Lower-Volatility Pick

ITGR doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.

Best for: healthcare exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM ranks third and is worth considering specifically for long-term compounding and valuation efficiency.

  • 481.2% 10Y total return vs MMSI's 249.4%
  • PEG 0.83 vs PEP's 5.04
  • Lower P/E (14.6x vs 15.0x), PEG 0.83 vs 3.40
  • +20.9% vs MMSI's -27.7%
Best for: long-term compounding and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthFORA logoFORA50.1% revenue growth vs KO's 1.9%
ValueJPM logoJPMLower P/E (14.6x vs 15.0x), PEG 0.83 vs 3.40
Quality / MarginsKO logoKO27.8% margin vs FORA's -17.0%
Stability / SafetyFORA logoFORABeta 0.21 vs JPM's 0.87, lower leverage
DividendsPEP logoPEP3.9% yield, 54-year raise streak, vs KO's 2.6%, (3 stocks pay no dividend)
Momentum (1Y)JPM logoJPM+20.9% vs MMSI's -27.7%
Efficiency (ROA)KO logoKO13.1% ROA vs FORA's -11.8%, ROIC 15.8% vs -7.5%

FORA vs MMSI vs KO vs PEP vs ITGR vs JPM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FORAForian Inc.
FY 2022
Information and Software
93.5%$26M
Service
5.5%$2M
Product and Service, Other
1.0%$274,256
MMSIMerit Medical Systems, Inc.
FY 2025
Cardiovascular
95.2%$1.4B
Endoscopy
4.8%$73M
KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B
PEPPepsiCo, Inc.

Segment breakdown not available.

ITGRInteger Holdings Corporation
FY 2025
Cardio And Vascular
59.7%$1.1B
Cardiac Rhythm Management & Neuromodulation
36.1%$669M
Other Markets
4.2%$78M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000

FORA vs MMSI vs KO vs PEP vs ITGR vs JPM — Financial Metrics

Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLKOLAGGINGITGR

Income & Cash Flow (Last 12 Months)

KO leads this category, winning 4 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 9328.3x FORA's $30M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to FORA's -17.0%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFORA logoFORAForian Inc.MMSI logoMMSIMerit Medical Sys…KO logoKOThe Coca-Cola Com…PEP logoPEPPepsiCo, Inc.ITGR logoITGRInteger Holdings …JPM logoJPMJPMorgan Chase & …
RevenueTrailing 12 months$30M$1.5B$49.3B$93.9B$1.8B$280.3B
EBITDAEarnings before interest/tax-$4M$290M$15.5B$14.3B$328M$81.4B
Net IncomeAfter-tax profit-$5M$139M$13.7B$8.2B$142M$57.0B
Free Cash FlowCash after capex$2M$274M$12.6B$7.7B$168M$100.9B
Gross MarginGross profit ÷ Revenue+46.8%+48.7%+61.7%+54.1%+23.3%+60.0%
Operating MarginEBIT ÷ Revenue-13.4%+12.2%+29.3%+12.2%+10.4%+25.9%
Net MarginNet income ÷ Revenue-17.0%+9.0%+27.8%+8.8%+7.7%+20.4%
FCF MarginFCF ÷ Revenue+7.8%+17.8%+25.5%+8.2%+9.1%+36.0%
Rev. Growth (YoY)Latest quarter vs prior year-2.9%+7.8%+12.1%+5.6%+0.8%
EPS Growth (YoY)Latest quarter vs prior year-2.0%+38.8%+18.2%+66.7%+172.7%+16.0%
KO leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — ITGR and JPM each lead in 3 of 7 comparable metrics.

At 16.2x trailing earnings, JPM trades at a 49% valuation discount to MMSI's 31.6x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.92x vs PEP's 7.25x — a lower PEG means you pay less per unit of expected earnings growth.

MetricFORA logoFORAForian Inc.MMSI logoMMSIMerit Medical Sys…KO logoKOThe Coca-Cola Com…PEP logoPEPPepsiCo, Inc.ITGR logoITGRInteger Holdings …JPM logoJPMJPMorgan Chase & …
Market CapShares × price$68M$4.0B$341.7B$194.1B$3.1B$908.6B
Enterprise ValueMkt cap + debt − cash$55M$4.5B$376.9B$234.8B$4.5B$1.51T
Trailing P/EPrice ÷ TTM EPS-23.48x31.56x26.12x23.67x31.47x16.22x
Forward P/EPrice ÷ next-FY EPS est.16.51x24.27x16.43x14.95x14.60x
PEG RatioP/E ÷ EPS growth rate2.34x7.25x7.15x0.92x
EV / EBITDAEnterprise value multiple13.98x25.45x16.42x13.46x18.52x
Price / SalesMarket cap ÷ Revenue2.24x2.65x7.13x2.07x1.70x3.25x
Price / BookPrice ÷ Book value/share2.27x2.57x9.99x9.48x1.85x2.51x
Price / FCFMarket cap ÷ FCF23.49x18.59x64.52x25.30x29.77x9.01x
Evenly matched — ITGR and JPM each lead in 3 of 7 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 5 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-17 for FORA. FORA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs JPM's 5/9, reflecting strong financial health.

MetricFORA logoFORAForian Inc.MMSI logoMMSIMerit Medical Sys…KO logoKOThe Coca-Cola Com…PEP logoPEPPepsiCo, Inc.ITGR logoITGRInteger Holdings …JPM logoJPMJPMorgan Chase & …
ROE (TTM)Return on equity-17.2%+8.9%+41.1%+40.1%+8.2%+15.9%
ROA (TTM)Return on assets-11.8%+5.2%+13.1%+7.7%+4.2%+1.3%
ROICReturn on invested capital-7.5%+7.2%+15.8%+14.9%+5.4%+4.5%
ROCEReturn on capital employed-8.2%+7.9%+17.3%+16.1%+6.9%+8.9%
Piotroski ScoreFundamental quality 0–9667555
Debt / EquityFinancial leverage0.00x0.57x1.33x2.43x0.80x2.60x
Net DebtTotal debt minus cash-$13M$450M$35.2B$40.7B$1.4B$599.0B
Cash & Equiv.Liquid assets$13M$449M$10.3B$9.2B$17M$343.3B
Total DebtShort + long-term debt$12,137$898M$45.5B$49.9B$1.4B$942.4B
Interest CoverageEBIT ÷ Interest expense-48.78x10.74x10.70x10.34x5.07x0.74x
KO leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $23,548 today (with dividends reinvested), compared to $1,735 for FORA. Over the past 12 months, JPM leads with a +20.9% total return vs MMSI's -27.7%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.7% vs MMSI's -6.8% — a key indicator of consistent wealth creation.

MetricFORA logoFORAForian Inc.MMSI logoMMSIMerit Medical Sys…KO logoKOThe Coca-Cola Com…PEP logoPEPPepsiCo, Inc.ITGR logoITGRInteger Holdings …JPM logoJPMJPMorgan Chase & …
YTD ReturnYear-to-date+2.4%-22.2%+16.4%+1.9%+18.5%+0.8%
1-Year ReturnPast 12 months+2.4%-27.7%+17.7%+14.5%-23.5%+20.9%
3-Year ReturnCumulative with dividends-7.3%-18.9%+39.3%-14.5%+6.5%+138.8%
5-Year ReturnCumulative with dividends-82.7%+11.6%+65.3%+15.2%+0.9%+135.5%
10-Year ReturnCumulative with dividends-90.5%+249.4%+115.0%+79.6%+183.0%+481.2%
CAGR (3Y)Annualised 3-year return-2.5%-6.8%+11.7%-5.1%+2.1%+33.7%
JPM leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — KO and JPM each lead in 1 of 2 comparable metrics.

KO is the less volatile stock with a -0.23 beta — it tends to amplify market swings less than JPM's 0.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 96.2% from its 52-week high vs MMSI's 69.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFORA logoFORAForian Inc.MMSI logoMMSIMerit Medical Sys…KO logoKOThe Coca-Cola Com…PEP logoPEPPepsiCo, Inc.ITGR logoITGRInteger Holdings …JPM logoJPMJPMorgan Chase & …
Beta (5Y)Sensitivity to S&P 5000.21x0.58x-0.23x-0.09x0.69x0.87x
52-Week HighHighest price in past year$2.71$96.74$84.04$171.48$123.78$338.09
52-Week LowLowest price in past year$1.64$59.74$65.35$127.60$62.00$269.72
% of 52W HighCurrent price vs 52-week peak+80.1%+69.5%+94.5%+82.8%+73.5%+96.2%
RSI (14)Momentum oscillator 0–10063.850.749.238.447.872.1
Avg Volume (50D)Average daily shares traded40K706K13.6M6.5M463K7.4M
Evenly matched — KO and JPM each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — KO and PEP each lead in 1 of 2 comparable metrics.

Analyst consensus: MMSI as "Buy", KO as "Buy", PEP as "Hold", ITGR as "Buy", JPM as "Buy". Consensus price targets imply 40.1% upside for MMSI (target: $94) vs 4.5% for JPM (target: $340). For income investors, PEP offers the higher dividend yield at 3.92% vs JPM's 1.83%.

MetricFORA logoFORAForian Inc.MMSI logoMMSIMerit Medical Sys…KO logoKOThe Coca-Cola Com…PEP logoPEPPepsiCo, Inc.ITGR logoITGRInteger Holdings …JPM logoJPMJPMorgan Chase & …
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuyBuy
Price TargetConsensus 12-month target$94.20$86.13$167.89$108.00$339.75
# AnalystsCovering analysts1448451561
Dividend YieldAnnual dividend ÷ price+2.6%+3.9%+1.8%
Dividend StreakConsecutive years of raises565415
Dividend / ShareAnnual DPS$2.04$5.57$5.95
Buyback YieldShare repurchases ÷ mkt cap+0.6%0.0%+0.2%+0.5%+1.6%+3.8%
Evenly matched — KO and PEP each lead in 1 of 2 comparable metrics.
Key Takeaway

KO leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). JPM leads in 1 (Total Returns). 3 tied.

Best OverallThe Coca-Cola Company (KO)Leads 2 of 6 categories
Loading custom metrics...

FORA vs MMSI vs KO vs PEP vs ITGR vs JPM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is FORA or MMSI or KO or PEP or ITGR or JPM a better buy right now?

For growth investors, Forian Inc.

(FORA) is the stronger pick with 50. 1% revenue growth year-over-year, versus 1. 9% for The Coca-Cola Company (KO). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 2x trailing P/E (14. 6x forward), making it the more compelling value choice. Analysts rate Merit Medical Systems, Inc. (MMSI) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — FORA or MMSI or KO or PEP or ITGR or JPM?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 2x versus Merit Medical Systems, Inc. at 31. 6x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 83x versus PepsiCo, Inc. 's 5. 04x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — FORA or MMSI or KO or PEP or ITGR or JPM?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +135. 5%, compared to -82. 7% for Forian Inc. (FORA). Over 10 years, the gap is even starker: JPM returned +481. 2% versus FORA's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — FORA or MMSI or KO or PEP or ITGR or JPM?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

23β versus JPMorgan Chase & Co. 's 0. 87β — meaning JPM is approximately -472% more volatile than KO relative to the S&P 500. On balance sheet safety, Forian Inc. (FORA) carries a lower debt/equity ratio of 0% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — FORA or MMSI or KO or PEP or ITGR or JPM?

By revenue growth (latest reported year), Forian Inc.

(FORA) is pulling ahead at 50. 1% versus 1. 9% for The Coca-Cola Company (KO). On earnings-per-share growth, the picture is similar: The Coca-Cola Company grew EPS 23. 6% year-over-year, compared to -15. 0% for Integer Holdings Corporation. Over a 3-year CAGR, FORA leads at 22. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — FORA or MMSI or KO or PEP or ITGR or JPM?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus -9. 5% for Forian Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -8. 2% for FORA. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is FORA or MMSI or KO or PEP or ITGR or JPM more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 83x versus PepsiCo, Inc. 's 5. 04x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 6x forward P/E versus 24. 3x for The Coca-Cola Company — 9. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMSI: 40. 1% to $94. 20.

08

Which pays a better dividend — FORA or MMSI or KO or PEP or ITGR or JPM?

In this comparison, PEP (3.

9% yield), KO (2. 6% yield), JPM (1. 8% yield) pay a dividend. FORA, MMSI, ITGR do not pay a meaningful dividend and should not be held primarily for income.

09

Is FORA or MMSI or KO or PEP or ITGR or JPM better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

23), 2. 6% yield, +115. 0% 10Y return). Both have compounded well over 10 years (KO: +115. 0%, ITGR: +183. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between FORA and MMSI and KO and PEP and ITGR and JPM?

These companies operate in different sectors (FORA (Healthcare) and MMSI (Healthcare) and KO (Consumer Defensive) and PEP (Consumer Defensive) and ITGR (Healthcare) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FORA is a small-cap high-growth stock; MMSI is a small-cap quality compounder stock; KO is a large-cap quality compounder stock; PEP is a mid-cap income-oriented stock; ITGR is a small-cap quality compounder stock; JPM is a large-cap deep-value stock. KO, PEP, JPM pay a dividend while FORA, MMSI, ITGR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.